1. Home
  2. CRNT vs CRBP Comparison

CRNT vs CRBP Comparison

Compare CRNT & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ceragon Networks Ltd.

CRNT

Ceragon Networks Ltd.

N/A

Current Price

$2.06

Market Cap

213.6M

Sector

Technology

ML Signal

N/A

CRBP

Corbus Pharmaceuticals Holdings Inc.

N/A

Current Price

$11.31

Market Cap

190.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRNT
CRBP
Founded
1996
2009
Country
Israel
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.6M
190.3M
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
CRNT
CRBP
Price
$2.06
$11.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$3.50
$45.50
AVG Volume (30 Days)
391.9K
516.3K
Earning Date
05-19-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
$9.11
N/A
Revenue Next Year
$6.70
$116.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
97.62
52 Week Low
$1.85
$7.12
52 Week High
$3.29
$20.56

Technical Indicators

Market Signals
Indicator
CRNT
CRBP
Relative Strength Index (RSI) 37.75 66.21
Support Level $1.96 $7.62
Resistance Level $2.36 $11.64
Average True Range (ATR) 0.06 0.60
MACD 0.00 0.07
Stochastic Oscillator 5.56 83.08

Price Performance

Historical Comparison
CRNT
CRBP

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport specialist, providing wireless connectivity solutions to markets globally across various industries, including wireless (mobile) network service providers and private networks, enabling them to build new networks and evolve networks towards 4G and 5G services. Its portfolio mainly comprises the IP-20 and IP-50 product series, including integrated multi-technology radio units operating across frequencies from 4 GHz to 86 GHz, as well as single-radio devices used for wireless data transport. Additionally, the company offers turnkey services including: network and radio planning, site survey, installation, network auditing and optimization, and more. Geographically, it derives maximum revenue from India, followed by North America and other regions.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: